Comparison Between Mediterranean Diet and High Protein Diet in Women With Polycystic Ovary Syndrome (PCOS)

NCT ID: NCT01615848

Last Updated: 2013-02-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2013-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Polycystic ovary syndrome (PCOS) affects 5-10% of women and is the most common endocrine syndrome.PCOS is associated with infertility, risk for obesity and type 2 diabetes. The elevated insulin characteristic of PCOS is likely to play a major role in its symptoms. restricted calorie High protein diet and mediterranean diet may improve insulin sensitivity and therefore lower androgen production in women with pcos women.the purpose of this study is to determine which diet is more effective in improving metabolic and reproductive outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome affecting 5-10% of women of reproductive age. It is characterized by elevated circulating insulin, reduced insulin sensitivity, infertility, hyperandrogenism, and a multitude of symptoms that result in a decreased quality of life. The elevated insulin characteristic of PCOS is likely to play a major role in its pathogenesis by reducing insulin sensitivity and stimulating excess androgen production hence causing an hormonal imbalance.

Low calories diets have shown to improve pcos symptoms but the optimal diet for all pcos women is still unknown.

In this study, our purpose is to compare two lowering insulin restricted calories diets in order to find the optimal diet for improving metabolic and endocrin outcomes in pcos women we will also investigate which diet has the best long lasting compliance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Polycystic Ovary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mediterranean diet restricted calorie

1500 k/calories 47-51% carbohydrate 14-17% protein 33-36% fat: 7-7.6% saturated fat 22-30% monounsaturated \& polyunsaturated fat

Group Type EXPERIMENTAL

mediterranean diet restricted calorie

Intervention Type OTHER

1500 k/cal 30% fat

mediterranean diet restricted calorie

Intervention Type OTHER

50 pcos women will be assigned to 1500 k/cal diet for 18 month

high protein diet, restricted calorie

1500 k/calories 40 % carbohydrate 30% protein 30% fat

Group Type EXPERIMENTAL

high protein diet

Intervention Type OTHER

50 pcos diagnosed women will be assigned to high protein diet for 18 month

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mediterranean diet restricted calorie

1500 k/cal 30% fat

Intervention Type OTHER

high protein diet

50 pcos diagnosed women will be assigned to high protein diet for 18 month

Intervention Type OTHER

mediterranean diet restricted calorie

50 pcos women will be assigned to 1500 k/cal diet for 18 month

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Polycystic ovary syndrome

Exclusion Criteria

* Pregnancy
* Lactation 6 month prior to study
* Known hyperandrogenism
* More then 5 kg weight loss 6 month prior to study
* Imbalance pituitary hormones
* Alcohol or drug abuse
* Chronic disease - kidney/heart/diabetes/lung
* Psychiatric disease
* Drug use accept contraceptive pills
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Meir Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adam Geva, MD

Role: PRINCIPAL_INVESTIGATOR

Clalit Health Services

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clalit Health Services

Haifa, Israel, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Adam Geva, MD

Role: primary

052-3562580

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MMC12043-20kCTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Microbiome and Polycystic Ovaries
NCT04836910 NOT_YET_RECRUITING